Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,567 | -15,007 | -7,264 | -26,457 | -21,023 |
| Depreciation Amortization | 3,402 | 2,219 | 1,109 | 4,273 | 3,173 |
| Accounts receivable | -4,767 | -2,811 | -3,608 | -3,099 | -3,661 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | -1,805 |
| Other Working Capital | -1,527 | -224 | -1,407 | 13,479 | 13,775 |
| Other Operating Activity | 5,788 | 3,377 | 3,894 | 4,062 | 5,803 |
| Operating Cash Flow | $-15,671 | $-12,446 | $-7,276 | $-7,742 | $-3,738 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -254 | -236 | -214 | 62 | -247 |
| PPE Investments | -599 | -207 | -170 | -686 | -498 |
| Other Investing Activity | -59 | -23 | 13 | 33 | 70 |
| Investing Cash Flow | $-912 | $-466 | $-371 | $-591 | $-675 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -4,752 | -4,752 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $-4,752 | $-4,752 |
| Exchange Rate Effect | 217 | 200 | 202 | -270 | -130 |
| Beginning Cash Position | 37,808 | 37,808 | 37,808 | 51,163 | 51,163 |
| End Cash Position | 21,442 | 25,096 | 30,363 | 37,808 | 41,868 |
| Net Cash Flow | $-16,366 | $-12,712 | $-7,445 | $-13,355 | $-9,295 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,671 | -12,446 | -7,276 | -7,742 | -3,738 |
| Capital Expenditure | -599 | -207 | -170 | -686 | -498 |
| Free Cash Flow | -16,270 | -12,653 | -7,446 | -8,428 | -4,236 |